Your browser doesn't support javascript.
loading
Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program).
Gaudet, Daniel; Watts, Gerald F; Robinson, Jennifer G; Minini, Pascal; Sasiela, William J; Edelberg, Jay; Louie, Michael J; Raal, Frederick J.
Afiliación
  • Gaudet D; Department of Medicine, ECOGENE-21 Clinical and Translational Research Center and Lipidology Unit, Université de Montréal, Chicoutimi, Quebec, Canada. Electronic address: daniel.gaudet@umontreal.ca.
  • Watts GF; Lipid Disorders Clinic, Centre for Cardiovascular Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia.
  • Robinson JG; University of Iowa, Iowa City, Iowa.
  • Minini P; Biostatistics and Programming, Sanofi, Chilly-Mazarin, France.
  • Sasiela WJ; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
  • Edelberg J; Sanofi, Bridgewater, New Jersey.
  • Louie MJ; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
  • Raal FJ; Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.
Am J Cardiol ; 119(1): 40-46, 2017 Jan 01.
Article en En | MEDLINE | ID: mdl-27793396
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Lipoproteína(a) / Hipercolesterolemia / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Am J Cardiol Año: 2017 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Lipoproteína(a) / Hipercolesterolemia / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Am J Cardiol Año: 2017 Tipo del documento: Article